Company / Free Cash Flow per Share
United Therapeutics Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$23.21
FY2025
5-year range
$10.73 / $23.21
FY2021-FY2025
Trend
+1.1%
vs FY2024
Sector context
#3 of 192
Health Care
What the data says
Among 192 Health Care companies, United Therapeutics is in the top 2% for free cash flow per share. Free Cash Flow per Share has increased for 4 consecutive years, from $10.73 in FY2021 to $23.21 in FY2025.
Based on SEC 10-K filings.
23.21 in FY2025 with a 5-year CAGR of +7.9%. Ranks 3rd among 192 companies in Health Care.
Improved from $16.24 to $23.21 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
+217.0% above sector average
Key checks
Key Insights
- United Therapeutics's free cash flow per share has grown for 4 consecutive years.
- In FY2025, free cash flow per share increased 1.1% year-over-year.
- Ranks #3 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.21 | +1.1% |
| FY2024 | $22.97 | +41.4% |
| FY2023 | $16.24 | +10.4% |
| FY2022 | $14.71 | +37.2% |
| FY2021 | $10.73 | -32.4% |
| FY2020 | $15.87 | +338.3% |
| FY2019 | -$6.66 | -148.5% |
| FY2018 | $13.74 | +77.2% |
| FY2017 | $7.75 | -41.4% |
| FY2016 | $13.23 | +87.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026